| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |